Beam Therapeutics (BEAM) creates precision genetic medicines with base editing to address serious diseases. It's cutting edge.
More from Investing
These recently downgraded names are displaying both quantitative and technical deterioration.
Looking to eliminate company-specific risk? Here's how I'd play these two popular exchange-traded funds.
Selecting and buying the right shares produces big profits -- but only when the conditions are right.
Military contractors tend to have strong performance, even amid recessions. Here are three names that could provide steady income now.